Abe Dunn
Bureau of Economic Analysis
51 Papers
285 Citations
Abe Dunn is an academic researcher from Bureau of Economic Analysis. The author has contributed to research in topics: Health care & Population. The author has an hindex of 14, co-authored 51 publications. Previous affiliations of Abe Dunn include Analysis Group & Government of the United States of America.
Chat about Author
Papers
US Health Care Spending by Payer and Health Condition, 1996-2016.
Joseph L Dieleman,Jackie Cao,Abby Chapin,Carina Chen,Zhiyin Li,Angela Liu,Cody Horst,Alexander S Kaldjian,Taylor Matyasz,Kirstin W. Scott,Anthony L. Bui,Madeline Campbell,Herbert C. Duber,Herbert C. Duber,Abe Dunn,Abraham D. Flaxman,Christina Fitzmaurice,Christina Fitzmaurice,Mohsen Naghavi,Nafis Sadat,Peter Shieh,Ellen Squires,Kai Yeung,Christopher J L Murray +23 more
TL;DR: National spending estimates stratified by health condition, age group, sex, type of care, and type of payer and modeled for each year from 1996 through 2016 show low back and neck pain had the highest amount of health care spending in 2016.
Adjusting Health Expenditures for Inflation: A Review of Measures for Health Services Research in the United States
TL;DR: There is no single gold standard for adjusting health expenditures for inflation, so suggestions on specific indexes to use in many common situations and general guidance in others are developed.
Do Physicians Possess Market Power
Abe Dunn,Adam Hale Shapiro +1 more
TL;DR: It is found that physicians in more concentrated markets charge higher service prices; a physicians in the 90th percentile of market concentration will charge 14–30 percent higher fees than a physician in the 10th percentile.
106
The Complexity Of Billing And Paying For Physician Care
TL;DR: This work develops new measures of billing complexity for physician care across insurers and over time, and estimates their costs using a large sample of detailed insurance "remittance data" for the period 2013-15, which found dramatic variation across different types of insurance.
81
•Book
Drug Innovations and Welfare Measures Computed from Market Demand: The Case of Anti-Cholesterol Drugs
Abe Dunn
- 08 Feb 2013
TL;DR: In this article, the authors apply demand estimation techniques to individual level data to construct a constant-quality price index for anti-cholesterol drugs and find that the constant quality price index drops by 27 percent, a pace more in line with their expectations in such a dynamic segment of the industry.
66